<?xml version="1.0" encoding="UTF-8"?>
<p id="par0210">There is an urgent and critical need to identify novel medical countermeasures both for prophylactic and treatment use. Since the production of a vaccine could take 12–18 months, and de novo development of therapies usually requires 10–17 years, repositioning clinically evaluated drugs represents one of the most practicable strategies for the rapid identification and deployment of treatments for emerging infectious diseases such as COVID-19 [
 <xref rid="bib0325" ref-type="bibr">65</xref>].
</p>
